Health state utility and quality of life measures in patients with chronic myeloid leukemia in France
S, Foulon, P, Cony-Makhoul, A, Guerci-Bresler, M, Daban, R, Kapso, P, Tubert-Bitter, J, Bonastre
Published in Quality of life research (01.07.2021)
Published in Quality of life research (01.07.2021)
Get full text
Journal Article
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial
Le Cesne, A., Blay, J.-Y., Cupissol, D., Italiano, A., Delcambre, C., Penel, N., Isambert, N., Chevreau, C., Bompas, E., Bertucci, F., Chaigneau, L., Piperno-Neumann, S., Salas, S., Rios, M., Guillemet, C., Bay, J.-O., Ray-Coquard, I., Haddag, L., Bonastre, J., Kapso, R., Fraslin, A., Bouvet, N., Mir, O., Foulon, S.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
Severe COVID-19 in patients with hematological cancers presenting with viremia
Michot, J.M., Hueso, T., Ibrahimi, N., Pommeret, F., Willekens, C., Colomba, E., Francis, S., Bayle, A., Cournède, P.H., Merad, M., Foulon, S., Albiges, L., Gachot, B., Barlesi, F., Soria, J.C., Ribrag, V., Griscelli, F.
Published in Annals of oncology (01.10.2021)
Published in Annals of oncology (01.10.2021)
Get full text
Journal Article
Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study
Cerbone, L., Combarel, D., Geraud, A., Auclin, E., Foulon, S., Alves Costa Silva, C., Colomba, E., Carril, L., Derosa, L., Flippot, R., Mir, O., Khoudour, N., Blanchet, B., Escudier, B., Paci, A., Albiges, L.
Published in ESMO open (01.12.2021)
Published in ESMO open (01.12.2021)
Get full text
Journal Article
Thrombolysis rate and impact of a stroke code: A French hospital experience and a systematic review
Dalloz, M.A, Bottin, L, Muresan, I.P, Favrole, P, Foulon, S, Levy, P, Drouet, T, Marro, B, Alamowitch, S
Published in Journal of the neurological sciences (15.03.2012)
Published in Journal of the neurological sciences (15.03.2012)
Get full text
Journal Article
Path integral approach to closed-form option pricing formulas with applications to stochastic volatility and interest rate models
Lemmens, D, Wouters, M, Tempere, J, Foulon, S
Published in Physical review. E, Statistical, nonlinear, and soft matter physics (01.07.2008)
Published in Physical review. E, Statistical, nonlinear, and soft matter physics (01.07.2008)
Get more information
Journal Article
1627P Long survivors after androgen deprivation therapy (ADT) with or without docetaxel for metastatic castration-sensitive prostate cancer (mCSPC): Long-term follow-up of GETUG-15
Blanchet-Deverly, S., Fizazi, K., Oudard, S., Gravis, G., Boughalem, E., Borchiellini, D., Foulon, S., Peyre Pradat, F., Beuzeboc, P., Mourey, L., Laguerre, B., Jacobs, M., Tosi, D., Priou, F., Sfumato, P., Massard, V.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1319P Impact of concomitant co-medications on survival with first-line pembrolizumab in 43,000 French patients with advanced NSCLC
Rousseau, A., Foulon, S., Simon-Tillaux, N., Michiels, S., Lolivier, A., Bonastre, J., Planchard, D., Barlesi, F., Remon Masip, J., Lavaud, P., Aldea, M., Frelaut, M., Parisi, C., Le Pechoux, C., Botticella, A., Levy, A., Gazzah, A., Besse, B.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
736P Residual masses after salvage chemotherapy in men with metastatic seminoma: The Semi-ResMass multicenter retrospective study
Baciarello, G., Brard, C., Baumert, H., De Giorgi, U.F.F., Flechon, A., Giannatempo, P., Gravis, G., Morelli, F., Pouessel, D., Vincenzi, B., Oing, C., Secondino, S., Ladoire, S., Crouzet, L., Naoun, N., Foulon, S., Fizazi, K.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Evaluating immunotherapy-related adverse events reporting in the French national hospital discharge database (PMSI): a pilot study
Deneche, I., Luu, J., Messayke, S., Laghouati, S., Bonastre, J., Marabelle, A., Foulon, S.
Published in Revue d'épidémiologie et de santé publique (01.03.2023)
Published in Revue d'épidémiologie et de santé publique (01.03.2023)
Get full text
Journal Article
1595MO Phenotypic and genomic characterization of de novo metastatic prostate cancer: An ancillary study of the PEACE-1 phase III trial
Pobel, C., Bargain, C., Scoazec, J., Rouleau, E., Roubaud, G., Ronchin, P., Supiot, S., Hasbini, A., Silva, M., Flechon, A., Laguerre, B., Lacourtoisie, S. Abadie, El Kouri, C., Mourey, L., Maurina, T., Martin, E., Ribault, H., Foulon, S., Fizazi, K., Loriot, Y.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1717TiP CARE1 pragmatic clinical trial: First line randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma
Albiges, L., Suarez Rodriguez, C., Procopio, G., Bex, A., Gruenwald, V., Schmidinger, M., Melichar, B., De Velasco Oria, G.A., Bergerot, C.D., Giles, R., Woodward, R., Ferreira, A.R., Rioux-Leclercq, N., Bonastre, J., Claveau, M., Flippot, R., Escudier, B., Foulon, S., Powles, T.B.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
603P Objective computerized cognitive assessment in men with metastatic castrate-resistant prostate cancer (mCRPC) randomly receiving darolutamide or enzalutamide in the ODENZA trial
Colomba, E., Jonas, S.F., Eymard, J-C., Delva, R., Brachet, P.E., Neuzillet, Y., Penel, N., Roubaud, G., Bompas, E., Mahammedi, H., Longo, R., Helissey, C., Barthelemy, P., Borchiellini, D., Hasbini, A., Priou, F., Saldana, C., Voog, E., Foulon, S., Fizazi, K.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial
Baudin, E., Walter, T.A., Beron, A., Smith, D., Hadoux, J., Lachachi, C., Taieb, D., Ansquer, C., Dierickx, L.O., de Mestier du Bourg, L., Deshayes, E., Quak, E., Dahan, L., Guimbaud, R., Touchefeu, Y., Haissaguerre, M., Do Cao, C., Lombard Bohas, C., Attard, M., Foulon, S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1421P Effect of abiraterone-prednisone in metastatic castration-sensitive prostate cancer (mCSPC) with neuroendocrine and very high-risk features in the PEACE-1 trial
Bernard-Tessier, A., Cancel, M., Tombal, B., Roubaud, G., Carles Galceran, J., Flechon, A., McDermott, R.S., Supiot, S., Berthold, D.R., Philippe, R., Kacso, G., Gravis Mescam, G., Calabrò, F., Berdah, J.F., Hasbini, A., Ricci, F., Hennequin, C., Ribault, H., Foulon, S., Fizazi, K.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article